Changeflow GovPing Healthcare & Life Sciences Diaphragmatic Breathing vs Incentive Spirometry...
Routine Notice Added Final

Diaphragmatic Breathing vs Incentive Spirometry for GERD - NCT07544433

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

Clinical trial NCT07544433 registered on ClinicalTrials.gov evaluates two non-invasive respiratory interventions—diaphragmatic breathing exercise (DBE) and volume-oriented incentive spirometry (VIS)—against standard care in patients with gastroesophageal reflux disease (GERD). The 6-week randomized controlled trial will measure outcomes including GERD symptom scores (GERDQ), esophageal acid exposure time, lower esophageal sphincter pressure, and health-related quality of life (GERD-HRQL). Three groups of participants will undergo baseline and post-intervention assessments with daily symptom and adherence diaries.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 676 changes logged to date.

What changed

A new clinical trial registration (NCT07544433) has been published on ClinicalTrials.gov, sponsored by NIH, studying the effects of diaphragm-oriented breathing training on gastroesophageal reflux disease. The randomized controlled trial will enroll participants assigned to one of three groups: diaphragmatic breathing exercise, volume-oriented incentive spirometry, or usual care control.

Healthcare providers and clinical investigators involved in GERD management or respiratory therapy research should note this trial's inclusion of both symptom-based (GERDQ) and quality-of-life (GERD-HRQL) endpoints, as well as esophageal function testing. The protocol may be relevant to those recruiting patients for gastroesophageal research or evaluating non-pharmacological GERD interventions.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Diaphragmatic Training on GERD

N/A NCT07544433 Kind: NA Apr 22, 2026

Abstract

he goal of this clinical trial is to evaluate the effects of diaphragm-oriented breathing training on patients with gastroesophageal reflux disease (GERD). This study will compare two non-invasive respiratory interventions-diaphragmatic breathing exercise (DBE) and volume-oriented incentive spirometry (VIS)-in terms of their impact on esophageal function and health-related quality of life.The main questions it aims to answer are:Does DBE or VIS improve GERD symptoms as measured by the GERD Questionnaire (GERDQ)?Do these interventions reduce esophageal acid exposure time and the number of reflux episodes?Do these interventions improve lower esophageal sphincter (LES) pressure and esophageal motility?Do these interventions improve GERD-related quality of life as measured by the GERD-HRQL questionnaire?Researchers will compare three groups: DBE, VIS, and a control group receiving standard care, to determine whether diaphragm-oriented breathing training provides additional benefits over usual management.Participants will:Be randomly assigned to one of three groups (DBE, VIS, or control)Perform the assigned intervention for 6 weeksUndergo baseline and post-intervention assessments, including symptom questionnaires and esophageal function testing Record symptoms and adherence in a daily diary

Conditions: GERD, Diaphragmatic Training

Interventions: Volume-oriented incentive spirometry, Diaphragmatic breathing exercise, Usual Care Group

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Respiratory therapy GERD treatment study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!